Aromatase inhibitors and contralateral breast cancer in BRCA mutation carriers
Author:
Funder
American Society of Clinical Oncology
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
https://link.springer.com/content/pdf/10.1007/s10549-022-06688-z.pdf
Reference36 articles.
1. Ford D et al (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 62(3):676–89
2. Metcalfe KA, Narod SA (2007) Breast cancer prevention in women with a BRCA1 or BRCA2 mutation. Open Med 1(3):e184–e190
3. Cortesi L, Rugo HS, Jackisch C (2021) An overview of PARP inhibitors for the treatment of breast cancer. Target Oncol 16(3):255–282
4. Kotsopoulos J (2018) Mutations and breast cancer prevention. Cancers (Basel) 10(12):524
5. Metcalfe K et al (2004) Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. J Clin Oncol 22(12):2328–2335
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The use of ribociclib in real clinical practice: results of a single-center observational retrospective study;Meditsinskiy sovet = Medical Council;2024-01-17
2. ER-positive and BRCA2-mutated breast cancer: a literature review;European Journal of Medical Research;2024-01-06
3. Progress and prospects in research and clinical practice of hormone receptor-positive, HER-2-negative breast cancer with BRCA1/2 mutations;Discover Oncology;2023-06-23
4. Systemic treatment of breast cancer in young patients with a germline mutation in the BRCA1 and BRCA2 genes;Onkologie;2023-06-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3